ProMIS Neurosciences Inc.

NASDAQ: PMN · Real-Time Price · USD
0.61
-0.02 (-3.17%)
At close: Aug 15, 2025, 3:59 PM
0.61
0.41%
After-hours: Aug 15, 2025, 07:17 PM EDT

ProMIS Neurosciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13.29M 16.69M 7.96M 21.43M
Short-Term Investments
33.05K 61.64K 59.46K 50.69K
Long-Term Investments
33.02M n/a n/a n/a
Other Long-Term Assets
n/a n/a 0.38 0.38
Receivables
78.03K n/a 71.63K n/a
Inventory
n/a n/a -71.63K -48.69K
Other Current Assets
5.13M 566.62K 4.62K 4.39K
Total Current Assets
18.91M 18.04M 9.35M 22.4M
Property-Plant & Equipment
n/a n/a 434.62 5.91K
Goodwill & Intangibles
n/a n/a 28.21K 34.92K
Total Long-Term Assets
n/a n/a 28.65K 40.83K
Total Assets
18.91M 18.04M 9.38M 22.44M
Account Payables
1.74M 10.39M 2.98M 408.98K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
2.22M n/a -1.05M 0.00
Total Current Liabilities
2.22M 12.39M 8.68M 1.17M
Long-Term Debt
n/a n/a n/a 4.94M
Other Long-Term Liabilities
204.85K 683.93K 1.86M 9.17M
Total Long-Term Liabilities
204.85K 683.93K 1.86M 14.11M
Total Liabilities
2.42M 13.07M 8.68M 15.28M
Total Debt
n/a n/a n/a 4.94M
Common Stock
n/a n/a n/a 56.51M
Retained Earnings
-90.69B -123.84M -108.66M -78.64M
Comprehensive Income
-371.18M -491.81K -264.52K -237.63K
Shareholders Equity
16.49B 4.97M -1.82M 7.16M
Total Investments
33.05M 61.64K 59.46K 50.69K